Related Experiment Video
Updated: Jul 14, 2026

Analysis of Fecal Microbiota Dynamics in Lupus-Prone Mice Using a Simple, Cost-Effective DNA Isolation Method
Published on: May 2, 2022
The Role of Gut Microbiota on Idiopathic Pulmonary Fibrosis Mediated by Circulating Inflammatory Proteins: A
Hongyu Zhu1, Caihua Chen1, Haixie Guo1
1Department of Thoracic Surgery, Taizhou Hospital, Taizhou, Zhejiang, China.
Background:
Persistent inflammation is a crucial characteristic of idiopathic pulmonary fibrosis (IPF). Gut microbiota (GM) contribute to the occurrence and development of several pulmonary diseases through the "gut-lung axis." The genetic role of GM in IPF and the mediating effect of circulating inflammatory proteins.
Methods:
A single nucleotide polymorphism (SNP) was used as an instrumental variable (IV) for exposure to evaluate the causal relationship between exposure and outcome. A two-step, two-sample Mendelian randomization study mainly based on an "inverse variance weighted (IVW)" approach was performed to explore the causal relationship between GM and IPF mediated by circulating inflammatory proteins.
Results:
The IVW way illustrated 12 taxa (Bacillales, Gastranaerophilales, Selenomonadales, Family XIII, Bacteroidaceae, Bacteroides, and Actinomyces, Bifidobacterium, Oscillibacter, Ruminococcus gnavus, Subdoligranulum, Veillonella) of GM and 8 circulating inflammatory proteins (CCL11, CXCL6, CXCL9, CCL8, CCL7, NRTN, STAMPB, and TGFa) had suggestive evidence of causality on IPF. The mediation MR demonstrated the causal pathway from Actinomyces to IPF was partly mediated by CCL11 (the mediation effect: 0.063, 95% CI [1.016-1.126]; p = 0.004) with a mediation proportion of 13.035%.
Conclusions:
These findings may suggest a genetically predicted association between GM and IPF mediated by circulating inflammatory proteins.
Insights
This study suggests gut microbiota influence idiopathic pulmonary fibrosis (IPF) through inflammatory proteins. Specific gut bacteria and proteins show a causal link to IPF, with Actinomyces and CCL11 partially mediating this relationship.
Area of Science:
- Genetics
- Microbiology
- Pulmonology
Background:
- Idiopathic pulmonary fibrosis (IPF) is characterized by persistent inflammation.
- The gut-lung axis highlights the gut microbiota's (GM) role in pulmonary diseases.
- Understanding GM's genetic influence on IPF is crucial.
Purpose of the Study:
- To investigate the causal relationship between gut microbiota and IPF.
- To explore the mediating role of circulating inflammatory proteins in this relationship.
- To leverage Mendelian randomization for genetic insights.
Main Methods:
- A two-sample Mendelian randomization study was conducted.
- Single nucleotide polymorphisms (SNPs) served as instrumental variables for GM exposure.
- The inverse variance weighted (IVW) method was primarily used.
Main Results:
- Twelve gut microbial taxa and eight inflammatory proteins showed suggestive causal links to IPF.
- A causal pathway from Actinomyces to IPF, mediated by CCL11, was identified.
- The mediation effect of Actinomyces on IPF via CCL11 was statistically significant.
Conclusions:
- A genetically predicted association exists between gut microbiota and IPF.
- Circulating inflammatory proteins play a mediating role in the gut-lung axis concerning IPF.
- These findings offer novel insights into IPF pathogenesis.
Related Concept Videos
Microbiota of the Respiratory Tract
Dysbiosis of the Gut Microbiota
Microbiota Modulation by Antibiotics
Inflammatory Bowel Disease III: Crohn's Disease

